Skip to main content

Algernon Health Inc(AGN-CN)
CSE

Today's Change
Delayed Last Update

Algernon Health Inc

601 West Broadway
Suite 400
Vancouver BC V5Z 4C2 CAN
P: 604-646-1553
https://www.algernonhealth.com

Sectors & Indices

Sector
Industry
Employees

Profile

Algernon Health Inc is a clinical-stage pharmaceutical development company focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), and stroke, including a program utilizing N,N-Dimethyltryptamine (DMT). Drug re-purposing (also known as re-profiling, re-tasking, or therapeutic switching) involves applying approved drugs and compounds to treat diseases. In addition, the Company is entering the Alzheimer's disease (AD) diagnostic market segment and plans to establish a network of dedicated neuroimaging medical clinics in North America, utilizing FDA-cleared, brain-specific PET scanners to focus on early-stage detection of the disease.

Key Executives

NameTitle
Information not available.

More from The Globe